MDXH MDxHealth
- 2.490
- +0.040+1.63%
MDxHealth News
MDxHealth (MDXH) Gets a Buy From BTIG
Analysts Conflicted on These Healthcare Names: MDxHealth (MDXH), OrthoPediatrics (KIDS) and Karuna Therapeutics (KRTX)
Piper Sandler Sticks to Its Buy Rating for MDxHealth (MDXH)
MDxHealth Analyst Ratings
BTIG Maintains Buy on MDxHealth, Raises Price Target to $8
Buy Rating Affirmed for MDxHealth Amid Strong Q4 Performance and Positive Future Outlook
Piper Sandler Sticks to Their Buy Rating for MDxHealth S.A. Sponsored ADR (MDXH)
MDxHealth S.A. Sponsored ADR (MDXH) Gets a Buy From BTIG
Strong Q3 Performance and Growth Prospects Reinforce Buy Rating for MDxHealth S.A.
Piper Sandler Maintains Overweight on MDxHealth, Lowers Price Target to $6-Report Released on 8th Nov 2023
MDxHealth Analyst Ratings
MDxHealth S.A. Sponsored ADR (MDXH) Receives a Buy From Piper Sandler
TD Cowen Keeps Their Buy Rating on MDxHealth S.A. Sponsored ADR (MDXH)
Analysts Are Bullish on These Healthcare Stocks: Terns Pharmaceuticals (TERN), MDxHealth S.A. Sponsored ADR (MDXH)
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), MDxHealth S.A. Sponsored ADR (MDXH) and Poseida Therapeutics (PSTX)
BTIG Sticks to Its Buy Rating for MDxHealth S.A. Sponsored ADR (MDXH)
TD Cowen Initiates Coverage On MDxHealth With Outperform Rating, Announces Price Target of $7
BTIG Adjusts Price Target on MDxHealth to $7 From $8, Maintains Buy Rating
BTIG Maintains Buy on MDxHealth, Lowers Price Target to $7
BTIG Reaffirms Their Buy Rating on MDxHealth S.A. Sponsored ADR (MDXH)
Analysis
Price Target
No Data
